These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 11372175)
1. [Clinical effectiveness of m-THPC-PEG in a new xenogenic animal tumor model for human squamous epithelial carcinomas]. Kübler AC; Reuther T; Staff C; Haase T; Flechtenmacher C; Benner A; Scheer M; Zillmann U Mund Kiefer Gesichtschir; 2001 Mar; 5(2):105-13. PubMed ID: 11372175 [TBL] [Abstract][Full Text] [Related]
2. The RAG 2 mouse model for xenografted human oral squamous cell carcinoma. Reuther T; Kübler AC; Staff CJ; Flechtenmacher C; Haase T; Zillmann U Contemp Top Lab Anim Sci; 2002 Mar; 41(2):31-5. PubMed ID: 11958601 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the in vivo efficiency of photofrin II-, mTHPC-, mTHPC-PEG- and mTHPCnPEG-mediated PDT in a human xenografted head and neck carcinoma. Reuther T; Kübler AC; Zillmann U; Flechtenmacher C; Sinn H Lasers Surg Med; 2001; 29(4):314-22. PubMed ID: 11746108 [TBL] [Abstract][Full Text] [Related]
4. Long circulating half-life and high tumor selectivity of the photosensitizer meta-tetrahydroxyphenylchlorin conjugated to polyethylene glycol in nude mice grafted with a human colon carcinoma. Westerman P; Glanzmann T; Andrejevic S; Braichotte DR; Forrer M; Wagnieres GA; Monnier P; van den Bergh H; Mach JP; Folli S Int J Cancer; 1998 Jun; 76(6):842-50. PubMed ID: 9626351 [TBL] [Abstract][Full Text] [Related]
5. Outcome of mTHPC mediated photodynamic therapy is primarily determined by the vascular response. Triesscheijn M; Ruevekamp M; Aalders M; Baas P; Stewart FA Photochem Photobiol; 2005; 81(5):1161-7. PubMed ID: 15934792 [TBL] [Abstract][Full Text] [Related]
6. Photodynamic mechanisms induced by a combination of hypericin and a chlorin based-photosensitizer in head and neck squamous cell carcinoma cells. Gyenge EB; Lüscher D; Forny P; Antoniol M; Geisberger G; Walt H; Patzke G; Maake C Photochem Photobiol; 2013; 89(1):150-62. PubMed ID: 22882495 [TBL] [Abstract][Full Text] [Related]
7. Foscan and foslip based photodynamic therapy in osteosarcoma in vitro and in intratibial mouse models. Meier D; Botter SM; Campanile C; Robl B; Gräfe S; Pellegrini G; Born W; Fuchs B Int J Cancer; 2017 Apr; 140(7):1680-1692. PubMed ID: 27943293 [TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy with mTHPC and polyethylene glycol-derived mTHPC: a comparative study on human tumour xenografts. Ris HB; Krueger T; Giger A; Lim CK; Stewart JC; Althaus U; Altermatt HJ Br J Cancer; 1999 Mar; 79(7-8):1061-6. PubMed ID: 10098737 [TBL] [Abstract][Full Text] [Related]
10. In vitro effects and localisation of the photosensitizers m-THPC and m-THPC MD on carcinoma cells of the human breast (MCF-7) and Chinese hamster fibroblasts (V-79). Hornung R; Jentsch B; Crompton NE; Haller U; Walt H Lasers Surg Med; 1997; 20(4):443-50. PubMed ID: 9142685 [TBL] [Abstract][Full Text] [Related]
11. Highly selective targeting of ovarian cancer with the photosensitizer PEG-m-THPC in a rat model. Hornung R; Fehr MK; Monti-Frayne J; Krasieva TB; Tromberg BJ; Berns MW; Tadir Y Photochem Photobiol; 1999 Oct; 70(4):624-9. PubMed ID: 10546556 [TBL] [Abstract][Full Text] [Related]
12. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo. Kirveliene V; Grazeliene G; Dabkeviciene D; Micke I; Kirvelis D; Juodka B; Didziapetriene J Cancer Chemother Pharmacol; 2006 Jan; 57(1):65-72. PubMed ID: 16001168 [TBL] [Abstract][Full Text] [Related]
13. The pharmacokinetic behavior of the photosensitizer meso-tetra-hydroxyphenyl-chlorin in mice and men. Triesscheijn M; Ruevekamp M; Out R; Van Berkel TJ; Schellens J; Baas P; Stewart FA Cancer Chemother Pharmacol; 2007 Jun; 60(1):113-22. PubMed ID: 17009028 [TBL] [Abstract][Full Text] [Related]
14. Optimizing photodynamic therapy: in vivo pharmacokinetics of liposomal meta-(tetrahydroxyphenyl)chlorin in feline squamous cell carcinoma. Buchholz J; Kaser-Hotz B; Khan T; Rohrer Bley C; Melzer K; Schwendener RA; Roos M; Walt H Clin Cancer Res; 2005 Oct; 11(20):7538-44. PubMed ID: 16243829 [TBL] [Abstract][Full Text] [Related]
15. Minimally-invasive debulking of ovarian cancer in the rat pelvis by means of photodynamic therapy using the pegylated photosensitizer PEG-m-THPC. Hornung R; Fehr MK; Monti-Frayne J; Tromberg BJ; Berns MW; Tadir Y Br J Cancer; 1999 Oct; 81(4):631-7. PubMed ID: 10574248 [TBL] [Abstract][Full Text] [Related]
16. Development of meta-tetrahydroxyphenylchlorin-monoclonal antibody conjugates for photoimmunotherapy. Vrouenraets MB; Visser GW; Stewart FA; Stigter M; Oppelaar H; Postmus PE; Snow GB; van Dongen GA Cancer Res; 1999 Apr; 59(7):1505-13. PubMed ID: 10197621 [TBL] [Abstract][Full Text] [Related]
17. Experimental model of invasion and metastasis by orthotopic transplantation of oral squamous and adenoid cystic carcinomas into the tongue of nude mice. Umeda M; Yokoo S; Komori T; Nishimatsu N; Shibuya Y; Fujioka M Br J Oral Maxillofac Surg; 2001 Oct; 39(5):376-80. PubMed ID: 11601820 [TBL] [Abstract][Full Text] [Related]
18. Effect of mTHPC-mediated photodynamic therapy on 5-fluorouracil resistant human colorectal cancer cells. Kukcinaviciute E; Sasnauskiene A; Dabkeviciene D; Kirveliene V; Jonusiene V Photochem Photobiol Sci; 2017 Jul; 16(7):1063-1070. PubMed ID: 28509917 [TBL] [Abstract][Full Text] [Related]
19. Topical application of temoporfin-loaded invasomes for photodynamic therapy of subcutaneously implanted tumours in mice: a pilot study. Dragicevic-Curic N; Gräfe S; Albrecht V; Fahr A J Photochem Photobiol B; 2008 Apr; 91(1):41-50. PubMed ID: 18316200 [TBL] [Abstract][Full Text] [Related]
20. Assessment of effect of photosensitizers on cytotoxicity of photodynamic therapy in human breast cancer cell cultures. Koechli OR; Schaer GN; Schenk V; Haller U; Walt H Arch Gynecol Obstet; 1995; 256(4):167-76. PubMed ID: 7503588 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]